Assessment of Parotid and Submandibular Glands With Shear Wave Elastography Following Radioactive Iodine Therapy for Papillary Thyroid Carcinoma

Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. Radioactive iodine (RAI) therapy is used for remnant ablation following thyroidectomy. Side effects such as dysphagia, xerostomia, and sialoadenitis may occur. We aimed to determine the differences in the parotid and submandibulary glands between healthy patients and patients with PTC who had undergone RAI therapy and have dry mouth symptoms using both shear wave elastography and ultrasonography.

[1]  A. Saraux,et al.  Can ARFI elastometry of the salivary glands contribute to the diagnosis of Sjögren's syndrome? , 2016, Joint, bone, spine : revue du rhumatisme.

[2]  C. Yazici,et al.  The role of shear wave elastography in the diagnosis of chronic autoimmune thyroiditis. , 2015, Medical ultrasonography.

[3]  R. Meier,et al.  Diagnostic utility of Acoustic Radiation Force Impulse (ARFI) imaging in primary Sjoegren`s syndrome , 2015, European Radiology.

[4]  Radu Badea,et al.  ARFI quantitative elastography of the submandibular glands. Normal measurements and the diagnosis value of the method in radiation submaxillitis. , 2013, Medical ultrasonography.

[5]  P. Rosário,et al.  Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin. , 2013, Thyroid : official journal of the American Thyroid Association.

[6]  S. Jeong,et al.  Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms. , 2013, Thyroid : official journal of the American Thyroid Association.

[7]  A. Okizaki,et al.  Assessment of Salivary Gland Dysfunction after Radioiodine Therapy for Thyroid Carcinoma Using Non-Contrast-Enhanced CT: The Significance of Changes in Volume and Attenuation of the Glands , 2012, American Journal of Neuroradiology.

[8]  A. Sanabria,et al.  Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer , 2011, Head & neck.

[9]  K. Lam,et al.  Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants , 2005, Endocrine pathology.

[10]  C. Ginter,et al.  The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. , 2003, Endocrine reviews.

[11]  M. Tuncel,et al.  Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine Treatment , 2002, Clinical nuclear medicine.

[12]  R. Solans,et al.  Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  M. Ringel,et al.  The Role of Radioactive Iodine in Salivary Gland Dysfunction , 2000, Ear, nose, & throat journal.

[14]  C. Kirsch,et al.  Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  S. J. Wang,et al.  Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. , 1996, Clinical nuclear medicine.

[16]  B. Malpani,et al.  Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. , 1996, International journal of radiation oncology, biology, physics.

[17]  B. Baum,et al.  99mTc-pertechnetate uptake in parotid acinar cells by the Na+/K+/Cl- co-transport system. , 1987, The Journal of clinical investigation.